Table. 1.

Baseline characteristics

Liver transplantation Value
Etiology
HBV 76 (52.8)
Alcoholics 28 (19.4)
NBNC 33 (23.6)
HCV 2 (1.4)
Others 5 (3.5)
Co-existence of HCC 97 (67.4)
MELD score 16 (6–40)
Type of liver transplantation
LDLT 84 (58.3)
DDLT 60 (41.7)
ABO-incompatible LDLT 16 (11.1)
Screening
Sex (male) 102 (70.8)
Age (yr) 58 (22–75)
Body mass index (kg/m2) 23.5 (16.5–31.4)
HBsAg (positive) 1 (0.7)
Anti-HCV (positive) 6 (4.2)
Period after liver transplantation (yr) 3 (1–12)
1–2 23 (16.0)
2–5 46 (31.9)
5–10 52 (36.1)
>10 23 (16.0)

Values are presented as number (%) or median (range).

HBV, hepatitis B virus; NBNC, non-B, non-C hepatitis; HCV, hepatitis C virus; HCC, hepatocellular carcinoma; MELD, model for end-stage liver disease; LDLT, living donor liver transplantation; DDLT, deceased donor liver transplantation; HBsAg, hepatitis B surface antigen.

Korean J Transplant 2021;35:168~176 https://doi.org/10.4285/kjt.21.0012
© Korean Journal of Transplantation